Inventor · disambiguated record
Thomas Wisniewski
Also filed as: WISNIEWSKI THOMAS · WISNIEWSKI THOMAS M
25 granted patents·9 pending applications·306 citations·filing 2001–2022
95Inventor score
Top patents by PatentIndex Score
34 records- 0197US6713450B2Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid depositsUNIV NEW YORK·Filed 2001·Granted Mar 30, 2004·132 cites·30 claims
- 0293US7479482B2Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid β, prion protein, amylin, α-synuclein, or polyglutamine repeats for induction of an immune response theretoUNIV NEW YORK·Filed 2002·Granted Jan 20, 2009·40 cites·8 claims
- 0389US7700107B2Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid depositsUNIV NEW YORK·Filed 2008·Granted Apr 20, 2010·12 cites·4 claims
- 0489US6821504B2Detection of alzheimer's amyloid by magnetic resonance imagingUNIV NEW YORK·Filed 2002·Granted Nov 23, 2004·45 cites·36 claims
- 0586US9574001B2Humanized single-chain antibody against beta 3 integrin for the treatment and prevention of metastasisWISNIEWSKI THOMAS M·Filed 2013·Granted Feb 21, 2017·12 cites·20 claims
- 0686US8409584B2Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteinsWISNIEWSKI THOMAS M·Filed 2010·Granted Apr 2, 2013·9 cites·30 claims
- 0785US9834582B2Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteinsUNIV NEW YORK·Filed 2015·Granted Dec 5, 2017·4 cites·23 claims
- 0884US7632816B2Treatment of Alzheimer amyloid depositionUNIV NEW YORK·Filed 2004·Granted Dec 15, 2009·18 cites·6 claims
- 0983US9409146B2Method for treating amyloid diseaseUNIV NEW YORK·Filed 2012·Granted Aug 9, 2016·3 cites·3 claims
- 1081US7427655B2Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid depositsUNIV NEW YORK·Filed 2003·Granted Sep 23, 2008·12 cites·9 claims
- 1177US8906382B2Method for treating amyloid diseaseWISNIEWSKI THOMAS·Filed 2012·Granted Dec 9, 2014·3 cites·4 claims
- 1276US8951519B2Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteinsUNIV NEW YORK·Filed 2013·Granted Feb 10, 2015·2 cites·25 claims
- 1373US10662246B2Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal dementias and traumatic brain injury/chronic traumatic encephalopathyUNIV NEW YORK·Filed 2018·Granted May 26, 2020·3 cites·19 claims
- 1472US8685718B2Mucosal immunization to prevent prion infectionWISNIEWSKI THOMAS·Filed 2004·Granted Apr 1, 2014·5 cites·15 claims
- 1572US8318175B2Method for treating amyloid diseaseFRANGIONE BLAS·Filed 2009·Granted Nov 27, 2012·3 cites·7 claims
- 1672US2023130218A1Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptidesUNIV NEW YORK·Filed 2022·Application pending·0 cites
- 1770US10383887B2Preventing and treating amyloid-beta deposition by stimulation of innate immunityWISNIEWSKI THOMAS·Filed 2009·Granted Aug 20, 2019·2 cites·26 claims
- 1870US9926353B2Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptidesWISNIEWSKI THOMAS M·Filed 2012·Granted Mar 27, 2018·1 cites·18 claims
- 1970US2009163420A1Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha-synuclein, or polyglutamine repeats for induction of an immune response theretoUNIV NEW YORK·Filed 2008·Application pending·0 cites
- 2067US11332506B2Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptidesUNIV NEW YORK·Filed 2018·Granted May 17, 2022·0 cites·23 claims
- 2166US10960019B2Preventing and treating amyloid-beta deposition by stimulation of innate immunityUNIV NEW YORK·Filed 2019·Granted Mar 30, 2021·0 cites·18 claims
- 2263US2022062320A1Preventing and treating amyloid- beta deposition by stimulation of innate immunityUNIV NEW YORK·Filed 2021·Application pending·0 cites
- 2362US9295719B2Method for treating amyloid diseaseUNIV NEW YORK·Filed 2014·Granted Mar 29, 2016·0 cites·14 claims
- 2461US10253070B2Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteinsUNIV NEW YORK·Filed 2017·Granted Apr 9, 2019·0 cites·15 claims
- 2561US9700607B2Mucosal immunization to prevent prion infectionUNIV NEW YORK·Filed 2014·Granted Jul 11, 2017·0 cites·14 claims
- 2661US8158380B2Imaging agents for protein misfoldingWISNIEWSKI THOMAS·Filed 2008·Granted Apr 17, 2012·0 cites·3 claims
- 2761US2023087558A1Methods and compositions for treating cerebral amyloid angiopathyUNIV NEW YORK·Filed 2022·Application pending·0 cites
- 2859US2021324110A1Specific murine and humanized monoclonal antibodies detecting pathology associated secondary structure changes in proteins and peptidesUNIV NEW YORK·Filed 2020·Application pending·0 cites
- 2955US9770496B2Method for treating amyloid diseaseUNIV NEW YORK·Filed 2016·Granted Sep 26, 2017·0 cites·16 claims
- 3053US10870709B2Specific murine and humanized monoclonal antibodies detecting pathology associated secondary structure changes in proteins and peptidesUNIV NEW YORK·Filed 2017·Granted Dec 22, 2020·0 cites·19 claims
- 3151US2007025931A1Powdery preparations containing 2.4.6-trianilino-p-(carbo-2'-ethylhexyl-1'-oxi)-1.3.5-triazineBASF AG·Filed 2004·Application pending·0 cites
- 3248US2022313802A1Compositions and methods for the treatment and prevention of prion diseaseUNIV NEW YORK·Filed 2020·Application pending·0 cites
- 3345US2007010435A1Method for treating amyloid diseaseUNIV NEW YORK·Filed 2003·Application pending·0 cites
- 3434US2018036433A1Compounds for the diagnosis or treatment of disorders associated with protein or peptide oligomersAGENCY SCIENCE TECH & RES·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Wisniewski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →